15 results
424B3
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
of the dCellVax gene-silenced dendritic cell immunotherapy for treating breast cancer. The proposed trial will recruit 10 patients with metastatic … will recruit 25 patients with metastatic cancer and will involve 3 monthly injections of the dCellVax gene-silenced dendritic cell therapy. The trial
10-K
2014 FY
RGBP
Regen BioPharma Inc
18 Dec 14
Annual report
12:00am
breast cancer. The proposed trial will recruit 10 patients with metastatic breast cancer and will involve 4 monthly injections of the dCellVax gene … immunotherapy for treating breast cancer. The proposed trial will recruit 10 patients with metastatic breast cancer and will involve 4 monthly
424B3
RGBP
Regen BioPharma Inc
15 May 23
Prospectus supplement
10:25am
of efficacy of the dCellVax gene-silenced dendritic cell immunotherapy for treating breast cancer. The proposed trial will recruit 10 patients with metastatic … will recruit 25 patients with metastatic cancer and will involve 3 monthly injections of the dCellVax gene-silenced dendritic cell therapy. The trial
424B3
dtaijrnn7 dv
2 Oct 23
Prospectus supplement
1:42pm
- Prev
- 1
- Next